维普期刊资源整合服务平台（V6.5）

65篇 您的检索式：作者名="Donnenberg AD"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Multiple drug resistance in cancer revisited:the cancer stem cell hypothesis显示文摘	Donnenberg VS Donnenberg AD	2005	J Clin Pharmacol2005，45，8：	1
2	Blood salvage and cancer surgery: should we do it显示文摘	Waters JH Donnenberg AD	2009	Transfusion2009，49，10：	1
3	EBVspecifc CD8+T cells from asymptomatic pediatric thoracic transplant patients carrying chronic high EBV loads display contrasting features:activated phenotype and exhausted function显示文摘	Macedo C Webber SA Donnenberg AD	2011	J Immunol2011，186，10：	1
4	Multiple drug resistance in cancer revisited:the cancer stem cell hypothesis显示文摘	Donnenberg VS Donnenberg AD	2005	J Clin Phamacol2005，45，8：	1
5	Multiple drug resistance in cancer revisited:the cancer stem cell hypothesis显示文摘	Dormenberg VS Donnenberg AD	2005	J Clin Pharmacol2005，45，8：	1
6	Rapid turnover of the CDS( + ) CD28( - ) T-cell subset of effector cells in the circulation of patients with head and neck cancer 显示文摘	Donnenberg AD Whiteside TL	2003	Cancer Immunol Immunother2003，52，10：	1
7	Lung T- cell subset composition at the time of surgical resection is a prognostic indicator in non-small cell lung cancer 显示文摘	Zikos TA Donnenberg AD Landreneau RJ	2011	Cancer Immunol Immunother2011，60，6：	1
8	Multiple drug resistance in cancer revisited:the cancer stem cell hypothesis显示文摘	Donnenberg VS Donnenberg AD	2005	J Clin Pharmacol2005，45，8：	1
9	Multiple drug resistance in cancer revisited: the cancer stem cell hypothesis显示文摘	Donnenberg VS Donnenberg AD	2005	J Clin Pharmacol2005，45，8：	1
10	Lung T-cell subset composition at the time of surgical resection is a prognostic indicator in non-small cell lung cancer 显示文摘	Zikos TA Donnenberg AD Landreneau RJ	2011	Cancer Immunol Immunother2011，60，6：	1
11	Intra-operative preparation of autologous bone marrow-derived CD34-enriched cellular products for cardiac therapy 显示文摘	Donnenberg AD Donnenberg VS Griffin DL	2011	Cytotherapy2011，13，4：	1
12	Multiple drug resistance in cancer revisited:the cancer stem cell hypothesis 显示文摘	DONNENBERG VS DONNENBERG AD	2005	J Clin Pharmacot2005，45，8：	1
13	Multiple drug resistance in cancer revisited: the cancer stem cell hypothesis显示文摘	Donnenberg VS Donnenberg AD	2005	J Clin Pharmacol2005，45，8：	1
14	Autologous peripheral blood stem cell transplantation and adoptive immunotherapy with activated natural killer cells in the immediate posttransplant period显示文摘	Lister J Rybka WB Donnenberg AD	1995	Clin Cancer Res1995，1，6：	1
15	Multiple drug resistance in cancer revisited: the cancer stem cell hypothesis 显示文摘	Donnenberg VS Donnenberg AD	2005	J Clin Pharmacol2005，45，8：	1
16	Multiple drug resistance in cancer revisited : the cancer stem cell hypothesis 显示文摘	Donnenberg VS Donnenberg AD	2005	J Clin Pharmacol2005，45，8：	1
17	Localization of CD44 and CDg0 positive cells to the invasive front of breast tumors 显示文摘	Donnenberg VS Donnenherg AD Zimmerlin L	2010	Cytometry B Clin Cytom2010，78，5：	1
18	Multiple drag resistance in cancer revisited: the cancer stem cell hypothesis 显示文摘	DONNENBERG VS DONNENBERG AD	2005	J Clin Pharmacol2005，45，8：	1
19	Rapid turnover of the CD8^+ CD28^+ T-cell subset of effector cells in the circulation of patients with head and neck cancer显示文摘	Tsukishiro T Donnenberg AD Whiteside TL	2003	Cancer Immunol Immunother2003，52，10：	1
20	Multiple drug resistance in cancer revisited:the cancer stem cell hypothesis显示文摘	DONNENBERG VS DONNENBERG AD	2005	Clin Pharmacol2005，45，8：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示